000 03053cam a2200349 a 4500
003 EG-GiCUC
005 20250223031838.0
008 171107s2017 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aPh.D
099 _aCai01.11.10.Ph.D.2017.Na.E
100 0 _aNadia Mohamed Shoukry
245 1 0 _aExpression of B and T iymphocyte attenuator, retinoid-related orphan receptor gamma-Isoform-t and interleukin 7 in psoriasis vulgaris /
_cNadia Mohamed Shoukry ; Supervised Randa Mohammad Youssef , Amany Zaki Elramly , Marwa Fathy Hussein
246 1 _aو انترلوكين7 فى الصدفيه التقليدية T الليمفاوية: مستقبل ريتينويد ذات الصلة جاما T و B التعبير الجينى لمضاعفات خلايا
260 _aCairo :
_bNadia Mohamed Shoukry ,
_c2017
300 _a122 P. :
_bcharts , facsimiles ;
_c25cm
502 _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Dermatology and Venerology
520 _aPsoriasis is one of the immune-mediated inflammatory diseases (IMID); Both CD4⁺ T lymphocytes mainly Th1 cells and B lymphocytes contribute in the pathogenesis of IMIDs through the proinflammatory effect and production of antibodies, activation of T cells, cytokine synthesis respectively. Gamma delta (Þe) T cells are capable of producing large amounts of IL-17 upon IL-23 stimulation. The capacity of Þe T cells to produce IL-17 is acquired during thymic differentiation, independent of TCR signaling, a feature pointing to their innate nature. B and T lymphocyte attenuator (BTLA) is a coinhibitory molecule expressed on T and B lymphocytes as well as other immune cells, it is necessary to inhibit homeostatic expansion and activation of lymph node and skin resident Þe T cells. BTLA expression is regulated by RORÞt and IL-7. RORÞt is a key transcription factor driving the Th17 differentiation producing IL-17 which plays a major role in psoriasis pathogenesis. IL-7 plays a role in psoriasis pathogenesis and is also critical for the normal homeostasis, function, expansion, and survival of adult Þe Tcells. Aim of study: To add more insight to the role played by co-inhibitory molecule BTLA in psoriasis vulgaris patients, by studying the gene expression of BTLA, RORÞt and IL-7 in psoriasis patients. It also aimed to analyze their inter-relationship. This aims at establishing a basis for novel treatment strategies for psoriasis. Patients and methods: This case control study included 25 patients and 25 controls examined for gene expression of BTLA, RORÞt and IL-7
530 _aIssued also as CD
653 4 _a BTLA
653 4 _aPsoriasis
653 4 _aÞe T cells
700 0 _aAmany Zaki Elramly ,
_eSupervisor
700 0 _aMarwa Fathy Hussein ,
_eSupervisor
700 0 _aRanda Mohammad Youssef ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aNazla
_eRevisor
905 _aShimaa
_eCataloger
942 _2ddc
_cTH
999 _c63339
_d63339